Isolagen's therapy to treat acne scars meets positive endpoints in phase-II/III study
Tuesday, March 10, 2009 17:00 IST Exton, Pennsylvania
Isolagen, Inc announced positive top-line efficacy results from a phase-II/III clinical study (Study IT-A-008) of the Isolagen Therapy for the treatment of moderate to severe acne scars.
